Skip links

Society for Immunotherapy of Cancer’s Annual Meeting, November 8–12, 2022, Boston, MA, US

Meet our CEO, Randolf Kerschbaumer at the SITC 37th Annual Meeting in Boston MA, USA, where he will present a poster on our novel oxMIF targeting antibody ON203 and its antitumorigenic activity.

Home